The age-related slow increase in amyloid pathology in APP.V717I mice activates microglia, but does not alter hippocampal neurogenesis

Lianne Hoeijmakers(Netherlands Institute for Neuroscience), Paul J. Lucassen(Netherlands Institute for Neuroscience), Silvie R. Ruigrok(Netherlands Institute for Neuroscience), Anne‐Marie van Dam(Amsterdam Neuroscience), Anikó Kőrösi(Netherlands Institute for Neuroscience), Janneke W. de Vries(Netherlands Institute for Neuroscience), Fred Van Leuven(KU Leuven), Gideon F. Meerhoff(Netherlands Institute for Neuroscience)
Neurobiology of Aging
September 22, 2017
10.1016/j.neurobiolaging.2017.09.013
Cited by 7

Related Papers

Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain
|Journal of Biological Chemistry|1999|668
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
|Journal of Clinical Investigation|2004|622
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice
|Brain|2005|562
Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency
|Proceedings of the National Academy of Sciences|1999|523
Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis
|Molecular and Cellular Biology|2012|473